Cutler Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,500
Closed -$88K 2021
2023
Q4
$88K Buy
1,500
+460
+44% +$27K 0.01% 547
2023
Q3
$45K Sell
1,040
-100
-9% -$4.33K ﹤0.01% 726
2023
Q2
$41K Sell
1,140
-100
-8% -$3.6K 0.01% 664
2023
Q1
$46K Sell
1,240
-4,360
-78% -$162K ﹤0.01% 655
2022
Q4
$253K Buy
5,600
+4,780
+583% +$216K 0.02% 391
2022
Q3
$57K Sell
820
-2,730
-77% -$190K ﹤0.01% 841
2022
Q2
$238K Buy
+3,550
New +$238K 0.02% 423
2022
Q1
Sell
-8,367
Closed -$1.23M 2751
2021
Q4
$1.23M Sell
8,367
-11,976
-59% -$1.76M 0.05% 237
2021
Q3
$3.6M Buy
+20,343
New +$3.6M 0.16% 90
2021
Q2
Hold
0
2873
2021
Q1
Sell
-1,268
Closed -$278K 2814
2020
Q4
$278K Buy
1,268
+105
+9% +$23K 0.01% 486
2020
Q3
$193K Sell
1,163
-1,141
-50% -$189K 0.01% 481
2020
Q2
$263K Buy
+2,304
New +$263K 0.02% 368
2020
Q1
Sell
-5,906
Closed -$761K 2200
2019
Q4
$761K Buy
5,906
+3,006
+104% +$387K 0.05% 241
2019
Q3
$225K Sell
2,900
-4,450
-61% -$345K 0.02% 409
2019
Q2
$757K Buy
+7,350
New +$757K 0.07% 188
2019
Q1
Sell
-801
Closed -$33K 2344
2018
Q4
$33K Sell
801
-8,599
-91% -$354K ﹤0.01% 957
2018
Q3
$442K Buy
+9,400
New +$442K 0.03% 373
2018
Q2
Sell
-1,206
Closed -$37K 2402
2018
Q1
$37K Buy
+1,206
New +$37K ﹤0.01% 1040
2017
Q4
Sell
-20,700
Closed -$242K 2979
2017
Q3
$242K Buy
20,700
+12,460
+151% +$146K 0.01% 679
2017
Q2
$30K Sell
8,240
-59,973
-88% -$218K ﹤0.01% 1697
2017
Q1
$354K Buy
68,213
+61,873
+976% +$321K 0.01% 591
2016
Q4
$30K Buy
6,340
+1,100
+21% +$5.21K ﹤0.01% 1746
2016
Q3
$34K Buy
5,240
+1,100
+27% +$7.14K ﹤0.01% 1606
2016
Q2
$22K Buy
4,140
+1,000
+32% +$5.31K ﹤0.01% 1779
2016
Q1
$67K Sell
3,140
-900
-22% -$19.2K ﹤0.01% 1146
2015
Q4
$127K Buy
+4,040
New +$127K 0.01% 925